search
Back to results

Social Phobia Intervention Study of Mannheim

Primary Purpose

Social Phobia

Status
Completed
Phase
Not Applicable
Locations
Germany
Study Type
Interventional
Intervention
cognitive therapy
stepped care program based on cognitive therapy
Sponsored by
Central Institute of Mental Health, Mannheim
About
Eligibility
Locations
Arms
Outcomes
Full info

About this trial

This is an interventional treatment trial for Social Phobia focused on measuring randomized controlled trial, stepped-care program, cognitive therapy of social phobia according to D.M. Clark

Eligibility Criteria

18 Years - 60 Years (Adult)All SexesDoes not accept healthy volunteers

Inclusion Criteria:

  • Diagnosis of Social Phobia according to the criteria of the Diagnostic and Statistical Manual of Mental Disorders IV (DSM-IV)
  • Duration of the disorder at least 1 year
  • Severity of symptomatology according to at least one of two self-report measures for social anxiety above Cut-Off: Social Interaction Anxiety Scale (SIAS: value of 26 or more) and / or Social Phobia Scale (SPS: value of 17 or more)
  • Age: 18-60
  • Written Informed Consent

Exclusion Criteria:

  • Social Phobia is not the main diagnosis
  • Mental Retardation
  • Lifetime Diagnoses: Schizophreniform Disorder, Bipolar Affective Disorder
  • Acute Diagnoses: severe Major Depression Episode, severe Anorexia Nervosa, Substance-, Drug - or Alcohol-Dependence, life-threatening suicidal crisis
  • Psychotropic medication (except stable treatment with antidepressant since 3 months before study start: medication and dosage has to be stable during the entire study duration)

Sites / Locations

  • Central Institute of Mental Health

Arms of the Study

Arm 1

Arm 2

Arm Type

Active Comparator

Active Comparator

Arm Label

SCP

ST

Arm Description

SCP is a stepped-care program with a self-help module with minimal therapist contact (8 sessions) as first step, followed by therapist-guided intervention depending on status of remission (8 sessions up to a maximum of 16 sessions).

A standard therapy which means a therapist-guided intervention with 16 sessions face-to-face therapy.

Outcomes

Primary Outcome Measures

Change From Baseline in Social Interaction Anxiety Scale (SIAS)
This scale measures interaction anxiety on a 5-point scale (range of scores is 0-4); the number of items is 20; the total minimum for all 20 items is 0 and the total maximum is 80; lower values consider better outcome.
Change From Baseline in Social Phobia Scale (SPS)
The scale measures social anxiety on a 5-point scale (range of score is 0-4) ; the number of items is 20; the total minimum for all 20 items is 0 and the total maximum is 80; lower values consider better outcome.
Change From Baseline in Liebowitz Social Anxiety Scale (LSAS)
The scale measures social anxiety and avoidance on a 4-point-scale (range of scores is 0-3). Blinded raters assessed social anxiety and avoidance behaviour relating to 24 social situations. Minimum for all 24 situations is 0, maximum for all 24 situations including the assessments for anxiety and avoidance is 144). Lower scores consider better outcome.

Secondary Outcome Measures

Change From Baseline in Brief Symptom Inventory (BSI)
The scale measures general psychopathology on 53 items on a 5-point scale (range of scores is 0-4). Minimum for all 53 items is 0, maximum is 212. Lower scores consider better outcome.
Change on Baseline in Center for Epidemiologic Studies Depression Scale (CES-D)
The scale measures depressive symptoms on 20 items on a 4-point scale (range of scores is 0-3; minimum for all 20 items is 0, maximum 60). Lower scores consider better outcome.

Full Information

First Posted
February 9, 2007
Last Updated
October 28, 2012
Sponsor
Central Institute of Mental Health, Mannheim
Collaborators
German Research Foundation
search

1. Study Identification

Unique Protocol Identification Number
NCT00434759
Brief Title
Social Phobia Intervention Study of Mannheim
Official Title
Evaluation of the Efficacy, Mechanisms of Change and Efficiency of a Stepped-care Program With a Computer-based Self-help Module and Minimal Therapist Contact in Comparison to a Standard Cognitive Therapy for Patients With Social Phobia
Study Type
Interventional

2. Study Status

Record Verification Date
October 2012
Overall Recruitment Status
Completed
Study Start Date
September 2006 (undefined)
Primary Completion Date
May 2009 (Actual)
Study Completion Date
December 2011 (Actual)

3. Sponsor/Collaborators

Responsible Party, by Official Title
Sponsor
Name of the Sponsor
Central Institute of Mental Health, Mannheim
Collaborators
German Research Foundation

4. Oversight

Data Monitoring Committee
Yes

5. Study Description

Brief Summary
Primary objective: The purpose of this study is to examine efficacy and efficiency of a Stepped Care Program (SCP) for patients with Social Phobia in comparison to the standard cognitive therapy for Social Phobia according to D.M. Clark. Secondary objective: Further, it is intended to identify mechanisms of change which mediate treatment outcome and to identify differential predictors for therapy success for the two treatment conditions.
Detailed Description
With prevalence rates (lifetime) up to 13% in western countries, Social Phobia is one of the most frequent mental disorders. Main objective of this clinical trial is the evaluation of the efficacy and efficiency of a stepped care program for patients with Social Phobia (SCP) as compared to a standard therapy (ST) for patients with social phobia. Both interventions are based on the cognitive therapy according to D.M. Clark. The SCP starts with a 8-sessions self-help-module with minimal therapist contact via email. Patients who do not reach remission after this first step, enter step 2 which consists of 8 therapy sessions guided by a therapist. If patients are not remitted after that, they receive another 8 sessions of therapist-guided cognitive treatment in step 3. So the SCP contains 8, 16 or 24 sessions of therapy - depending on remission status of the patient. In contrast to that, the ST comprises 16 sessions of therapist-guided intervention. The diagnostic status of the patients is assessed by blinded clinician raters before treatment, after every eighth therapy session, and at 5 follow-up timepoints in order to examine the stability of treatment effects (3, 6, 9, 12 and 30 months after the end of therapy). Besides efficacy and efficiency of the SCP vs. ST, mechanisms of change and differential predictors for therapy outcome will be investigated. Hypotheses: We expect that the SCP is significantly more effective than the ST. the SCP is significantly more efficient than the ST. the results referring to the efficacy will be stable up to 30 months after the end of treatment(Follow Up Phase). the SCP will cause less primary and secondary costs than the ST. successful therapy leads to an improvement in the following areas: reduction of biased information processing, reduction of negative thoughts, subjective anxiety, safety behaviors, self-focused attention and autonomic arousal in anxiety-provoking situations, amelioration of verbal and non-verbal social competence in anxiety- provoking situations. As mediators of change, the factors maintaining social anxiety according to the model of Social Phobia by Clark and Wells (1995) will be investigated.

6. Conditions and Keywords

Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Social Phobia
Keywords
randomized controlled trial, stepped-care program, cognitive therapy of social phobia according to D.M. Clark

7. Study Design

Primary Purpose
Treatment
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Masking
Outcomes Assessor
Allocation
Randomized
Enrollment
89 (Actual)

8. Arms, Groups, and Interventions

Arm Title
SCP
Arm Type
Active Comparator
Arm Description
SCP is a stepped-care program with a self-help module with minimal therapist contact (8 sessions) as first step, followed by therapist-guided intervention depending on status of remission (8 sessions up to a maximum of 16 sessions).
Arm Title
ST
Arm Type
Active Comparator
Arm Description
A standard therapy which means a therapist-guided intervention with 16 sessions face-to-face therapy.
Intervention Type
Behavioral
Intervention Name(s)
cognitive therapy
Other Intervention Name(s)
cognitive therapy of social phobia according to D.M. Clark
Intervention Description
changing safety behaviors, self-focused attention, and automatic negative thoughts in anxiety-provoking situations via cognitive techniques, for example role plays and behavioral experiments
Intervention Type
Behavioral
Intervention Name(s)
stepped care program based on cognitive therapy
Other Intervention Name(s)
based on cognitive therapy for social phobie by Clark & Wells (1995)
Intervention Description
starting with a digital-video-disk-based (DVD-based) self-help module (8 Sessions) followed by face-to-face-therapy including 8 or 16 sessions depending on remission status; including: changing safety behaviors, self-focused attention, and automatic negative thoughts in anxiety-provoking situations via cognitive techniques, for example role plays and behavioral experiments
Primary Outcome Measure Information:
Title
Change From Baseline in Social Interaction Anxiety Scale (SIAS)
Description
This scale measures interaction anxiety on a 5-point scale (range of scores is 0-4); the number of items is 20; the total minimum for all 20 items is 0 and the total maximum is 80; lower values consider better outcome.
Time Frame
baseline to post-treatment (on average 24 weeks)
Title
Change From Baseline in Social Phobia Scale (SPS)
Description
The scale measures social anxiety on a 5-point scale (range of score is 0-4) ; the number of items is 20; the total minimum for all 20 items is 0 and the total maximum is 80; lower values consider better outcome.
Time Frame
baseline to post-treatment (on average 24 weeks)
Title
Change From Baseline in Liebowitz Social Anxiety Scale (LSAS)
Description
The scale measures social anxiety and avoidance on a 4-point-scale (range of scores is 0-3). Blinded raters assessed social anxiety and avoidance behaviour relating to 24 social situations. Minimum for all 24 situations is 0, maximum for all 24 situations including the assessments for anxiety and avoidance is 144). Lower scores consider better outcome.
Time Frame
baseline to post-treatment (on average 24 weeks)
Secondary Outcome Measure Information:
Title
Change From Baseline in Brief Symptom Inventory (BSI)
Description
The scale measures general psychopathology on 53 items on a 5-point scale (range of scores is 0-4). Minimum for all 53 items is 0, maximum is 212. Lower scores consider better outcome.
Time Frame
baseline to post-treatment (on average 24 weeks)
Title
Change on Baseline in Center for Epidemiologic Studies Depression Scale (CES-D)
Description
The scale measures depressive symptoms on 20 items on a 4-point scale (range of scores is 0-3; minimum for all 20 items is 0, maximum 60). Lower scores consider better outcome.
Time Frame
baseline to post-treatment (on average 24 weeks)

10. Eligibility

Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
60 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria: Diagnosis of Social Phobia according to the criteria of the Diagnostic and Statistical Manual of Mental Disorders IV (DSM-IV) Duration of the disorder at least 1 year Severity of symptomatology according to at least one of two self-report measures for social anxiety above Cut-Off: Social Interaction Anxiety Scale (SIAS: value of 26 or more) and / or Social Phobia Scale (SPS: value of 17 or more) Age: 18-60 Written Informed Consent Exclusion Criteria: Social Phobia is not the main diagnosis Mental Retardation Lifetime Diagnoses: Schizophreniform Disorder, Bipolar Affective Disorder Acute Diagnoses: severe Major Depression Episode, severe Anorexia Nervosa, Substance-, Drug - or Alcohol-Dependence, life-threatening suicidal crisis Psychotropic medication (except stable treatment with antidepressant since 3 months before study start: medication and dosage has to be stable during the entire study duration)
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
Martin Bohus, MD
Organizational Affiliation
Central Institute of Mental Health in Mannheim
Official's Role
Study Director
Facility Information:
Facility Name
Central Institute of Mental Health
City
Mannheim
State/Province
Baden-Württemberg
ZIP/Postal Code
68159
Country
Germany

12. IPD Sharing Statement

Learn more about this trial

Social Phobia Intervention Study of Mannheim

We'll reach out to this number within 24 hrs